DST Global
Global investment firm founded by Yuri Milner, known for early investments in Facebook, Twitter, and Alibaba. Invests in high-growth technology companies globally, with selective healthcare and life sciences investments.
Website
https://dst-global.comLocation
Hong Kong / London
Founded
2009
AUM
$50B+
Investment Range
$50M - $500M
Portfolio Companies
1
Focus
generalist
Fund Stages
series-c, growth
Investment Thesis
DST Global invests in high-growth technology and internet companies globally, taking significant positions in category-defining platforms. In healthcare, they back technology-enabled companies at scale, including genomics diagnostics and digital health platforms.
Team
Partners / Managing Directors (Health & Bio Focus)
- Yuri Milner - Founder
- Rahul Mehta - Managing Partner
- Saurabh Gupta - Managing Partner
- John Lindfors - Managing Partner
Other Key Team Members
- Global investment team across multiple offices
Focus Areas
- Technology
- Internet
- Digital Health
- Genomics
- Consumer
- E-commerce
- Fintech
Notable Exits
- Foundation Medicine - Acquired (2018, by Roche for $2.4B) - early backer
- Facebook - IPO (2012, NASDAQ: META)
- Alibaba - IPO (2014, NYSE: BABA)
Portfolio Companies (Healthcare)
- Foundation Medicine (genomic profiling - exited)
Sources
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Foundation Medicine | Cambridge, Massachusetts, USA | 2010 | genomics-sequencingdiagnostics+3 |